TranS1 has begun a search for his replacement, and Mr. Luetkemeyer will serve as a consultant to the company during the transition, according to the release.
Read the TranS1 release about Michael Luetkemeyer.
TranS1 Announces Departure of CFO
Wilmington, N.C.-based TranS1, a medical device company focused on designing, developing and marketing products that implement its proprietary minimally invasive surgical approach to treat degenerative disc disease and instability affecting the lower lumbar region of the spine, has announced that Michael Luetkemeyer, CFO, will leave the company on March 31, 2010 to pursue other opportunities, according to a TranS1 news release.
